Supplementary figures for Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis
Published: 9 January 2024| Version 1 | DOI: 10.17632/tk68xz7nmh.1
Contributors:
Hélène Bugaut, Hervé Maillard, Caroline Jacobzone Leveque, Naeda Haddad, Francois Le Pelletier, Frédéric Charlotte, Michel Arock, Patrice Dubreuil, Cristina Bulai Livideanu, olivier Hermine, Stéphane BareteDescription
This set of supplementary figures illustrates additional content of the article "Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis"
Files
Institutions
- Assistance Publique - Hopitaux de Paris
- Sorbonne Universite
- Hopitaux Universitaires Pitie Salpetriere-Charles Foix
Categories
Dermatology, Cladribine, Systemic Mastocytosis, Mastocytosis